Temozolomide-Resistant Glioma Cells Are Sensitive to Chloroethylating Nitrosourea Compounds in Combination with ATR Inhibitors

被引：0
|
作者：
Jackson, C. [1 ]
Kalathil, A. N. [1 ]
Sundaram, R. K. [2 ]
Bindra, R. S. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Yale Univ, Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.1098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3481
引用
收藏
页码：E639 / E639
页数：1
相关论文
共 50 条
  • [21] LEVETIRACETAM DOWNREGULATES O6-METHYLGUANINE DNA METHYLTRANSFERASE EXPRESSION AND SENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS
    Saito, Norihiko
    Aoki, Kazuya
    Hirai, Nozomi
    Ishii, Masashi
    Tani, Mariko
    Sato, Kenichiro
    Nakayama, Haruo
    Harashina, Junichi
    Izukura, Hideaki
    Ito, Keisuke
    Sakurai, Takatoshi
    Iwabuchi, Satoshi
    NEURO-ONCOLOGY, 2014, 16
  • [22] NRF2 Modulates Ferroptosis in Temozolomide-Resistant Glioblastoma Cells
    Souza, Izadora
    Guedes, Camila
    Seregni, Linda
    Gomes, Luciana
    Rocha, Clarissa
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 117 - 117
  • [23] Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
    Gong, Lingli
    Yin, Ying
    Chen, Cheng
    Wan, Quan
    Xia, Die
    Wang, Mei
    Pu, Zhening
    Zhang, Bo
    Zou, Jian
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [24] Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
    Lingli Gong
    Ying Yin
    Cheng Chen
    Quan Wan
    Die Xia
    Mei Wang
    Zhening Pu
    Bo Zhang
    Jian Zou
    Cell Death Discovery, 8
  • [25] Temozolomide-resistant glioblastoma cells are collaterally sensitive to ferroptosis through NRF2 high expression.
    de Souza, Izadora
    Monteiro, Linda Karolynne
    Guedes, Camila Banca
    Latancia, Marcela
    Andrade, Marina Tomaz
    Silva, Matheus Molina
    Contieri, Bruna
    Milazzotto Ribeiro, Bruna Felicio
    Lazarini, Mariana
    Gomes, Luciana
    Rocha, Clarissa
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
    Quinn, Jennifer A.
    Jiang, Sara Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Friedman, Allan H.
    Bigner, Darell D.
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Walker, Amy
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1262 - 1267
  • [27] NRF2 Modulates Ferroptosis in Temozolomide-Resistant Glioblastoma Cells
    Roubicek, Deborah
    Bemis, Jeffrey
    Souza, Izadora
    Guedes, Camila
    Seregni, Linda
    Gomes, Luciana
    Rocha, Clarissa
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 : 72 - 72
  • [28] Temozolomide-resistant MGMT/MSI double-negative cancer cells rely on ATR signaling and homologous recombination for DNA repair and survival
    El Touny, Lara H.
    Harris, Erik
    Hose, Curtis
    Connelly, John
    Monks, Anne
    Newton, Dianne
    Stockwin, Luke
    Hollingshead, Melinda
    Parchment, Ralph
    Doroshow, James H.
    Teicher, Beverly A.
    Rapisarda, Annamaria
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [29] Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells
    Uzzaman, Mahmud
    Keller, Gordon
    Germano, Isabelle M.
    JOURNAL OF NEUROSURGERY, 2007, 106 (04) : 646 - 651
  • [30] NRF2 Modulates Ferroptosis in Temozolomide-Resistant Glioblastoma Cells.
    Souza, I
    Tomaz, M. A.
    Monteiro, L. K. S.
    Guedes, C. B.
    Silva, M. M.
    Porchia, B. F. M. M.
    Latancia, M. T.
    Lazarini, M.
    Gomes, L. R.
    Rocha, C. R. R.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2021, 62 : 72 - 72
12345